Drug Shortage Report for ACTONEL DR
Report ID | 95288 |
Drug Identification Number | 02370417 |
Brand name | ACTONEL DR |
Common or Proper name | risedronate |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-10-07 |
Actual start date | 2019-10-04 |
Estimated end date | 2019-10-21 |
Actual end date | 2019-10-03 |
Shortage status | Avoided shortage |
Updated date | 2019-10-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-10-03 | English | Compare |
v2 | 2019-10-03 | French | Compare |
v3 | 2019-10-03 | English | Compare |
v4 | 2019-10-03 | French | Compare |
Showing 1 to 4 of 4